StockData
DataMeds AI, Inc. logo

DataMeds AI, Inc. (MEDS) income statement

MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.73−0.01 (-1.53%)

Close on Nov 19, 2026Market cap $2.23MP/E –Yield –

DataMeds AI, Inc. income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
-92.1%
Operating margin
-548.1%
Net margin
-564.8%
Return on equity, FY2025
3545.2%

Financial strength

Current ratio
0.14
Debt to equity
-10.71
Debt to assets
46.9%
Cash to current liabilities
1.3%

Valuation

P/E ratio
–
Price to sales
0.29
Price to book
–
Dividend yield
–

See a number that looks wrong?